Home>Topics>>Can You Handle Risk? With A Dozen Clinical Trials, Exelixis Has Strong Upside Potential

Can You Handle Risk? With A Dozen Clinical Trials, Exelixis Has Strong Upside Potential

Healthcare Sector and Stocks Analysis from Seeking Alpha

Tue, 19 Aug 2014

By Christopher F. Davis : As a PhD-level epidemiologist and market analyst, there is no sector more interesting to me than biotech. I have opined on several of these names in the past. Those of you who follow my work know that I search for companies that are near-completion of developing new drugs, ...

Related Topics:

  1. Biotechnology
  2. Exelixis
  3. NASDAQ

Related Videos

  1. Tech Opportunities Powering Up for Health Care

    Wed, 5 Jun 2013

    A sea change of trends in the health-care industry will be a boon for IT investments, and the firms that can limit costs are the growth businesses of tomorrow, says Fidelity's Eddie Yoon.

  2. A Good Seed at This Wide-Moat Firm

    Thu, 12 Jun 2014

    Year-in and year-out, this company modifies its genetic material to produce seeds that out-yield the competition.

Content Partners